Does Dr. FLOR ABALOS ESCALONA have financial conflicts of interest?

Dr. FLOR ABALOS ESCALONA (APRN-FNP) has received a total of $1,870 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $1,870 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FLOR ABALOS ESCALONA?

According to CMS Open Payments data, Dr. FLOR ABALOS ESCALONA received funding from AMGEN ($306), ASTRAZENECA PHARMACEUTICALS ($219), and BAYER HEALTHCARE PHARMACEUTICALS ($202).

Does Dr. FLOR ABALOS ESCALONA receive research grants or speaking fees?

Dr. FLOR ABALOS ESCALONA has received $1,870 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FLOR ABALOS ESCALONA

APRN-FNPReal-Time Hydrated

Specialty: Family Medicine

Practice Location: MIAMI, FL 33175

NPI Number: 1639992498

LIFETIME INDUSTRY VALUE

$1,870

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ABALOS ESCALONA is a verified Family Medicine practitioner based in MIAMI, FL.

Between 2021 and 2025, Dr. ABALOS ESCALONA had an overall industry promotional and research financial footprint of $1,870 as recorded in the federal CMS Open Payments database.

$1,870 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ABALOS ESCALONA's primary funding source is AMGEN, which accounts for $306 (representing 16.4% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

AMGEN

Rank 1

$306

16.4%

ASTRAZENECA PHARMACEUTICALS

Rank 2

$219

11.7%

BAYER HEALTHCARE PHARMACEUTICALS

Rank 3

$202

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.